The challenge of follow-up in narrowband ultraviolet B phototherapy

British Journal of Dermatology

Volumn 157, Issue 2, 2007, Pages 344-349

  Diffey, B L ^a   Farr, P M ^b  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Follow up studies; Narrowband ultraviolet B; Skin cancer risk; Ultraviolet B phototherapy

Indexed keywords

ARTICLE; CANCER RISK; FEMALE; FOLLOW UP; HUMAN; MALE; MATHEMATICAL MODEL; PHOTOTHERAPY; PRIORITY JOURNAL; SKIN CANCER; ULTRAVIOLET B RADIATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; PSORIASIS; RESEARCH DESIGN; RISK ASSESSMENT; SKIN NEOPLASMS; ULTRAVIOLET THERAPY;

EID: 34447500363     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.07980.x     Document Type: Article

References (27)

1. Ibbotson SH, Bilsland D, Cox NH et al. An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology Group Workshop Report. Br J Dermatol 2004 151 : 283 97.
2. Zanolli M. Phototherapy treatment of psoriasis today. J Am Acad Dermatol 2003 49 : S78 86.
3. Pasker-de Jong PCM, Wielink G, van der Valk PGM, van der Wilt G-J. Treatment with UV-B for psoriasis and nonmelanoma skin cancer: a systematic review of the literature. Arch Dermatol 1999 135 : 834 40.
4. Lee E, Koo J, Berger T. UVB phototherapy and skin cancer risk: a review of the literature. Int J Dermatol 2005 44 : 355 60.
5. Young A. Carcinogenicity of UVB phototherapy assessed. Lancet 1995 345 : 1431 2.
6. van Weelden H, Baart-de la Faille H, Young E, van der Leun JC. A new development in UVB phototherapy of psoriasis. Br J Dermatol 1988 119 : 11 19.
7. Flindt-Hansen H, McFadden N, Eeg-Larsen T, Thune P. Effect of a new narrow-band UVB lamp on photocarcinogenesis in mice. Acta Derm Venereol (Stockh) 1991 71 : 245 8.
8. Wulf HC, Hansen AB, Bech-Thomsen N. Differences in narrow-band ultraviolet B and broad-spectrum ultraviolet photocarcinogenesis in lightly pigmented hairless mice. Photodermatol Photoimmunol Photomed 1994 10 : 192 7.
9. Gibbs NK, Traynor NJ, MacKie RM et al. The phototumorigenic potential of broad-band (270-350 nm) and narrow-band (311-313 nm) phototherapy sources cannot be predicted by their edematogenic potential in hairless mouse skin. J Invest Dermatol 1995 104 : 359 63.
10. Commission Internationale de l'Éclairage. CIE Standard. Photocarcinogenesis Action Spectrum (Non-melanoma Skin Cancers). CIE S 019/E-2006. Vienna : CIE, 2006.
11. Kirke S, Lowder S, Lloyd JJ et al. A randomized comparison of selective broadband UVB and narrowband UVB in the treatment of psoriasis. Br J Dermatol 2005 153 (Suppl. 1 10 (Abstract).
12. Yones SS, Palmer RA, Garibaldinos TT, Hawk JL. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy. Arch Dermatol 2006 142 : 836 42.
13. Stern RS, Lange R, members of the photochemotherapy follow-up study. Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. J Invest Dermatol 1988 91 : 120 4.
14. Weischer M, Blum A, Eberhard F et al. No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy; a first retrospective study. Acta Derm Venereol (Stockh) 2004 84 : 370 4.
15. Man I, Crombie IK, Dawe RS et al. The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data. Br J Dermatol 2005 152 : 755 7.
16. Black RJ, Gavin AT. Photocarcinogenic risk of narrowband ultraviolet B (TL-01) phototherapy: early follow-up data. Br J Dermatol 2006 154 : 566 7.
17. Cancer Research UK. London, 2006 http://www.cancerresearchuk.org/ (accessed 26 March 2007).
18. Armitage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer 1954 8 : 1 12.
19. Fears TR, Scotto J, Schneiderman MA. Mathematical models of age and ultraviolet effects on the incidence of skin cancer among whites in the United States. Am J Epidemiol 1977 105 : 420 7.
20. Slaper H, van der Leun JC. Quantitative modelling of skin cancer incidence. In : Human Exposure to Ultraviolet Radiation: Risks and Regulations (Passchier WF, Bosnjakovic BFM, eds). Amsterdam : Elsevier, 1987 155 71.
21. Diffey BL. Towards optimal regimens for the UVB phototherapy of psoriasis: a mathematical model. Acta Derm Venereol (Stockh) 2004 84 : 259 64.
22. Commission Internationale de l'Éclairage. CIE Standard. Erythema Reference Action Spectrum and Standard Erythema Dose. CIE S 007/E-1998. Vienna : CIE, 1998.
23. Harrison GI, Young AR. Ultraviolet radiation-induced erythema in human skin. Methods 2002 28 : 14 19.
24. Diffey BL. Human exposure to solar ultraviolet radiation. J Cosmet Dermatol 2002 1 : 124 30.
25. Bland JM, Altman DG. The odds ratio. Br Med J 2000 320 : 1468.
26. Risk analysis of human skin cancer. In : Health Effects from Ultraviolet Radiation. Report of an Advisory Group on Non-ionising Radiation, Documents of the NRPB, Vol. 6, No. 2. Chilton : National Radiological Protection Board, 1995 143 58.
27. Diffey BL. Factors affecting the choice of a ceiling on the number of exposures with TL01 ultraviolet B phototherapy. Br J Dermatol 2003 149 : 428 30.